Oldest pages
Showing below up to 50 results in range #3,501 to #3,550.
- Anti-bacterial agent (09:30, 3 February 2024)
- Antibiotic (09:30, 3 February 2024)
- Antibiotic prophylaxis (09:31, 3 February 2024)
- Antibiotic resistance (09:31, 3 February 2024)
- Antibody (09:31, 3 February 2024)
- Antibody formation (09:32, 3 February 2024)
- Antibody specificity (09:32, 3 February 2024)
- Antibody therapy (09:32, 3 February 2024)
- Anticachexia agent (09:32, 3 February 2024)
- Anticholesteremic agents (09:33, 3 February 2024)
- Anticholinergic agent (09:33, 3 February 2024)
- Anticoagulant (09:33, 3 February 2024)
- Anticonvulsant (09:34, 3 February 2024)
- Antidepressant (09:34, 3 February 2024)
- Antidiarrheal (09:34, 3 February 2024)
- Antidote (09:35, 3 February 2024)
- Antiemetic (09:35, 3 February 2024)
- Antifibrinolytic agent (09:35, 3 February 2024)
- Antifungal agent (09:35, 3 February 2024)
- Antigen (09:36, 3 February 2024)
- Antigen binding (09:36, 3 February 2024)
- Antigen presentation (09:36, 3 February 2024)
- Antigen receptor (09:37, 3 February 2024)
- Antigenic variation (09:37, 3 February 2024)
- Antigen-presenting cell (09:37, 3 February 2024)
- Antihypertensive agent (09:38, 3 February 2024)
- Anti-idiotype antibody (09:38, 3 February 2024)
- Anti-infective agent (09:38, 3 February 2024)
- Antileukemic agent (09:39, 3 February 2024)
- Antilymphocyte serum (09:39, 3 February 2024)
- Antimalarial (09:39, 3 February 2024)
- Antimetabolite (09:39, 3 February 2024)
- Antimitotic (09:40, 3 February 2024)
- Antimony (09:40, 3 February 2024)
- Antineoplastic (09:40, 3 February 2024)
- Antineoplastic antibiotic (09:41, 3 February 2024)
- Antiparkinson agent (09:49, 3 February 2024)
- Antiphospholipid syndrome (09:49, 3 February 2024)
- Antiplatelet agent (09:50, 3 February 2024)
- Antiporter activity (09:50, 3 February 2024)
- Antiprotozoal agent (09:50, 3 February 2024)
- Antipsychotic agent (09:51, 3 February 2024)
- Antipyretic (09:51, 3 February 2024)
- Antipyrine (09:51, 3 February 2024)
- Antiretroviral therapy (09:52, 3 February 2024)
- Antirheumatic agents (09:52, 3 February 2024)
- Antisense oligonucleotide (09:52, 3 February 2024)
- Antisense RNA (09:52, 3 February 2024)
- Antisense therapy (09:53, 3 February 2024)
- Antisepsis (09:53, 3 February 2024)
